Literature DB >> 2496145

Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.

O Miura1, S Hirosawa, A Kato, N Aoki.   

Abstract

The present study was designed to elucidate the molecular genetic basis of a familial deficiency of alpha 2-plasmin inhibitor (alpha 2PI). Southern blot hybridization analysis with human alpha 2PI cDNA and genomic DNA probes demonstrated no gross deletion or rearrangement of the gene. By sequencing all the coding exons and exon-intron boundaries of the gene of a homozygote, we identified a single cytidine nucleotide insertion in the exon coding for the carboxyl-terminal region. This frameshift mutation leads to an alteration and elongation of the carboxyl-terminal portion of the deduced amino acid sequence. Synthetic oligonucleotide probes confirmed this frameshift mutation in all the affected family members including both heterozygous parents. In a transient expression assay, the alpha 2PI level in the culture medium of the cells transfected with the mutated alpha 2PI expression vector was very low and only 4% of that of the cells transfected with the normal vector, although the transcript levels and the cellular contents of alpha 2PIs did not differ significantly. Elongation of amino acid sequence in the mutant alpha 2PI was confirmed by an analysis of alpha 2PI in a transient expression experiment. These data indicate that this mutation is the cause of alpha 2PI deficiency in this pedigree.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496145      PMCID: PMC303866          DOI: 10.1172/JCI114057

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Natural inhibitors of fibrinolysis.

Authors:  N Aoki
Journal:  Prog Cardiovasc Dis       Date:  1979 Jan-Feb       Impact factor: 8.194

2.  EB virus-induced B lymphocyte cell lines producing specific antibody.

Authors:  M Steinitz; G Klein; S Koskimies; O Makel
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

3.  Organization of the human alpha 2-plasmin inhibitor gene.

Authors:  S Hirosawa; Y Nakamura; O Miura; Y Sumi; N Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

6.  Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor.

Authors:  N Aoki; Y Sakata; M Matsuda; K Tateno
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

7.  Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.

Authors:  N Aoki; H Saito; T Kamiya; K Koie; Y Sakata; M Kobakura
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

Authors:  N Aoki; M Moroi; M Matsuda; K Tachiya
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.

Authors:  M Moroi; N Aoki
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

Review 10.  Hemostasis associated with abnormalities of fibrinolysis.

Authors:  N Aoki
Journal:  Blood Rev       Date:  1989-03       Impact factor: 8.250

View more
  6 in total

1.  Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT----GGAG).

Authors:  C P Nogueira; M C McGuire; C Graeser; C F Bartels; M Arpagaus; A F Van der Spek; H Lightstone; O Lockridge; B N La Du
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

2.  Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.

Authors:  E M Wallace; S J Perkins; R B Sim; A C Willis; C Feighery; J Jackson
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

Review 3.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

4.  Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.

Authors:  H Iwahana; K Yoshimoto; T Shigekiyo; A Shirakami; S Saito; M Itakura
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

5.  Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele.

Authors:  R Taramelli; M Pontoglio; G Candiani; S Ottolenghi; H Dieplinger; A Catapano; J Albers; C Vergani; J McLean
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

6.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.